Yongxin Zhang

Appearances

FUSOBACTERIUM NUCLEATUM FACILITATES ANTI-PD-1 THERAPY IN MICROSATELLITE STABLE COLORECTAL CANCER
Date
May 20, 2024
BACKGROUND: Around 80-85% of colorectal cancer (CRC) belongs to ‘immune cold’ microsatellite stable (MSS) subtype without responsive to anti-PD-1 mAb therapy…
Presenter
Xueliang Wang
Speakers
Yi Fang
Wei Liang
Chi Chun Wong
Meinong Liang
Lei Song
Yongxin Zhang
Miao Fan
Xiaoxing Li
Lixia Xu
Jun Yu
The Chinese University of Hong Kong
TUMOR-RESIDENT PROBIOTIC CLOSTRIDIUM BUTYRICUM FACILITATES IMMUNE THERAPY IN COLORECTAL CANCER BY TARGETING SECD-GRP78 AXIS
Date
May 20, 2024
BACKGROUND: _Clostridium butyricum_ is a known probiotic bacterium with anti-inflammatory activity. We found that it is depleted in patients with colorectal cancer (CRC) from multiple cohorts. Here, we examined the immunomodulatory effect of _C…
Presenter
Mingxu Xie
Speakers
Yating Zhang
Kai Yuan
Yongxin Zhang
Wenchao Wei
Lanping Jiang
Tianhui Li
Ruyi Zhang
Jun Yu
The Chinese University of Hong Kong